Genetics of Cushing's disease. (22nd September 2017)

• Record Type: Journal Article
• Authors: Albani, Adriana; Theodoropoulou, Marily; Reincke, Martin
• Is Part Of: Clinical endocrinology. Volume 88:Number 1(2018)
• Page Start: 3
• Page End: 12
• Publication Date: 2017-09-22
• Subjects: Adrenocorticotropic hormone -- corticotropinoma -- cortisol -- Cushing's syndrome -- mutation -- pituitary adenoma; Endocrinology -- Periodicals; 616.4005
• DOI: 10.1111/cen.13457
• Languages: English
• ISSNs: 0300-0664

Abstract

Summary: Cushing's disease (CD) is a rare disabling condition caused by Adrenocorticotropic hormone (ACTH)‐secreting adenomas of the pituitary. The majority of corticotropic adenomas are monoclonal and occur sporadically. Only rarely does CD arise in the context of genetic familial syndromes. Targeted sequencing of oncogenes and tumour suppressor genes commonly mutated in other tumours did not identify recurrent mutations. In contrast, next generation sequencing allowed us recently to clarify the genetic basis of CD: we identified somatic driver mutations in the ubiquitin‐specific protease 8 (USP8) gene in a significant portion of corticotropinomas. These mutations represent a novel and unique mechanism leading to ACTH excess. Inhibition of USP8 or its downstream signalling pathways could represent a new therapeutic approach for the management of CD. In this review, we will focus on this new evidence and its implication for clinical care of affected patients.